Prothena Corp. Plc (PRTA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Arrowhead Pharmaceuticals, Inc.

Blueprint Medicines Corp.

Axsome Therapeutics, Inc.

Krystal Biotech, Inc.

Intellia Therapeutics, Inc.

Prothena Corp. Plc

BridgeBio Pharma, Inc.

CRISPR Therapeutics AG

ImmunoGen, Inc.

Denali Therapeutics, Inc.

Mirati Therapeutics, Inc.

Why is Prothena Corp. Plc ?

Poor Management Efficiency with a low ROE of 3.07%

The company has been able to generate a Return on Equity (avg) of 3.07% signifying low profitability per unit of shareholders funds

Flat results in Dec 25

NET PROFIT(9M) At USD -153.82 MM has Grown at -207.2%
NET SALES(HY) At USD 2.44 MM has Grown at -21.24%
RAW MATERIAL COST(Y) Grown by 101.79% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -28.82%, its profits have fallen by -75%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -28.82% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Prothena Corp. Plc for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Prothena Corp. Plc

-28.82%

-0.94

59.54%

S&P 500

11.87%

0.62

19.30%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

57.95%

EBIT Growth (5y)

-18.35%

EBIT to Interest (avg)

-111.73

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.95

Sales to Capital Employed (avg)

0.19

Tax Ratio

4.83%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

3.07%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.76

EV to EBIT

-1.02

EV to EBITDA

-1.04

EV to Capital Employed

-7.82

EV to Sales

19.52

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-76.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bullish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

OPERATING PROFIT(Q)

Highest at USD -27.21 MM

PRE-TAX PROFIT(Q)

Highest at USD -24.59 MM

NET PROFIT(Q)

Highest at USD -24.6 MM

EPS(Q)

Highest at USD -0.4

-12What is not working for the Company

NET PROFIT(9M)

At USD -153.82 MM has Grown at -207.2%

NET SALES(HY)

At USD 2.44 MM has Grown at -21.24%

RAW MATERIAL COST(Y)

Grown by 101.79% (YoY

Here's what is working for Prothena Corp. Plc

Operating Profit

Highest at USD -27.21 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -24.59 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit

At USD -24.59 MM has Grown at 52.18%

over average net sales of the previous four periods of USD -51.42 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD -24.6 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit

At USD -24.6 MM has Grown at 60.23%

over average net sales of the previous four periods of USD -61.84 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD -0.4

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Prothena Corp. Plc

Net Sales

At USD 2.44 MM has Grown at -21.24%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Raw Material Cost

Grown by 101.79% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales